Sign In

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

Past Press Releases - KINAXO Biotechnologies GmbH

March 15, 2011
KINAXO extends collaboration with Takeda
KINAXO Biotechnologies GmbH announced today that it has entered a second collaboration with Takeda Pharmaceutical Company Limited Osaka, Japan. More

November 20, 2009
KINAXO completes financing round to enhance biomarker development
KINAXO Biotechnologies GmbH announces the completion of a financing round, gaining two new investors in the company, Leifina and Conmit Invest. More

October 21, 2009
KINAXO starts collaboration with Roche in the field of phosphoproteomics
KINAXO Biotechnologies GmbH announced today that it has entered into a collaboration with Roche Diagnostics GmbH in Penzberg, Germany. More

October 15, 2009
KINAXO Biotechnologies and Bayer Vital collaborate in phosphoproteomics biomarker identification
KINAXO Biotechnologies and Bayer Vital GmbH collaborate in phosphoproteomics biomarker identification. More

October 1, 2009
KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue
KINAXO Biotechnologies GmbH announced today that it added KinAffinity to its service portfolio. More

April 29, 2009
KINAXO’s Cellular Target Profiling reveals mTOR as a new target of Celebrex
Kinaxo Biotechnologies GmbH has successfully applied its Cellular Target Profiling technology to identify the protein kinase mTOR as a new cellular target of celecoxib (Celebrex, Pfizer). More

October 15, 2008
KINAXO enters into US and Japanese partnerships to introduce its Cellular Target Profiling Service
KINAXO Biotechnologies GmbH announced today that it has entered into strategic sales and marketing partnerships with BioCatalyst International and BioFocus DPI to support the introduction of KINAXO's proprietary Cellular Target Profiling Service within the US and Japanese market. More

October 13, 2008
Kinaxo enters into an agreement with Boehringer Ingelheim
Kinaxo Biotechnologies GmbH announced today that it has entered into a two-year collaboration with Boehringer Ingelheim. More


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 15€6.0MArtificial Intelligence
Nov 15€3.5MSoftware development
Nov 15N/AInternet services
Nov 15€2.4MMaterials
Nov 14N/AE-Commerce
Nov 14€3.1MMedical devices
Nov 14€4.5MOther Software

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...

About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.